Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 051788/0797 | |
| Pages: | 5 |
| | Recorded: | 02/11/2020 | | |
| Attorney Dkt #: | 1065272.000437 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
2
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/18/2021
|
Application #:
|
15105871
|
Filing Dt:
|
06/17/2016
|
|
Publication #:
|
|
Pub Dt:
|
12/22/2016
| | | | |
|
Title:
|
CANCER TREATMENTS USING COMBINATIONS OF TYPE 2 MEK AND ERK INHIBITORS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/25/2021
|
Application #:
|
15105924
|
Filing Dt:
|
06/17/2016
|
|
Publication #:
|
|
Pub Dt:
|
11/03/2016
| | | | |
|
Title:
|
CANCER TREATMENTS USING COMBINATIONS OF CDK AND ERK INHIBITORS
|
|
|
Assignee
|
|
|
|
|
| 4435 MAIN STREET, SUITE 550 |
| KANSAS CITY, MISSOURI 64111 |
|
|
Correspondence name and address
|
| |
BRYAN CAVE LEIGHTON PAISNER LLP
|
| |
1290 AVENUE OF THE AMERICAS
|
| |
NEW YORK, NY 10104
|
Search Results as of:
06/03/2024 11:56 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
